Uncategorized OIG Offers Compliance Tips for Healthcare Boards, Executives Thomas Sullivan Mar 28, 2013 0 Two of the most recent settlements involving pharmaceutical companies alleged to have engaged in off-label promotion, included…
FDA Court Upholds InterMune Executive Conviction on Misleading Speech Thomas Sullivan Mar 28, 2013 0 In December of last year, we reported on a landmark ruling from the United States Court of Appeals for the Second Circuit (New…